ALO Collaborates with The Education University of Hong Kong
ACN Newswire
HONG KONG, Mar 26, 2024 - (ACN Newswire) - ALO Parent Education App/Digital Platform (ALO) is collaborating with The Education..
HONG KONG, Mar 26, 2024 - (ACN Newswire) - ALO Parent Education App/Digital Platform (ALO) is collaborating with The Education..
Phase 3 RESILIENT study of TNX-102 SL successfully demonstrated daily pain reduction over placebo (primary endpoint, p =..
· Phase III PSMAfore trial with Pluvicto™ met its primary endpoint of radiographic progression-free survival (rPFS) with a HR of..